Gilead Sciences

By person

34 insiders · 311 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

MARTIN JOHN C

Director

—

$131.54M (51) scheduled

−$131.54M

2,887,225

0.2328%

$419.48M

−7.8%

Dickinson Andrew D

Chief Financial Officer

—

$62.18M (31) scheduled

−$62.18M

164,096

0.0132%

$23.84M

—

O'Day Daniel Patrick

Chairman & CEO

—

$55.82M (35) scheduled

−$55.82M

581,683

0.0469%

$84.51M

—

Mercier Johanna

Chief Comm & Corp Aff Officer

—

$31.91M (42) scheduled

−$31.91M

116,684

0.0094%

$16.95M

—

Alton Gregg H

Chief Patient Officer

—

$25.70M (31) scheduled

−$25.70M

58,046

0.0047%

$8.43M

−61.9%

Parsey Merdad

Chief Medical Officer

—

$22.24M (19) scheduled

−$22.24M

82,850

0.0067%

$12.04M

—

MILLIGAN JOHN F

President and CEO

—

$16.03M (1) scheduled

−$16.03M

1,574,306

0.1270%

$228.73M

+48.7%

Meyers James R

EVP Worldwide Commercial Ops

—

$13.02M (4) scheduled

−$13.02M

137,476

0.0111%

$19.97M

+7.5%

Pletcher Brett A

EVP,Corp Affairs & Gen Counsel

—

$9.34M (24) scheduled

−$9.34M

33,426

0.0027%

$4.86M

+373.7%

WILSON GAYLE E

Director

—

$8.84M (4) scheduled

−$8.84M

129,052

0.0104%

$18.75M

+22.5%

MADIGAN JOHN W

Director

—

$7.86M (1) scheduled

−$7.86M

18,548

0.0015%

$2.69M

+10.7%

Cogan John Francis

Director

—

$7.52M (28) scheduled

−$7.52M

54,860

0.0044%

$7.97M

+19.8%

Telman Deborah H

EVP, Corporate Affairs & GC

—

$6.59M (3) scheduled

−$6.59M

43,676

0.0035%

$6.35M

+6,538%

Washington Robin L

EVP, CFO

—

$4.81M (3) scheduled

−$4.81M

138,943

0.0112%

$20.19M

+6.1%

Wilfong Diane E.

Interim Corp Controller & CAO

—

$3.79M (4) scheduled

−$3.79M

46,259

0.0037%

$6.72M

+137.5%

WOLD OLSEN PER

Director

—

$3.19M (3) scheduled

−$3.19M

102,060

0.0082%

$14.83M

+11.5%

Bluestone Jeffrey

Director

—

$3.14M (9) scheduled

−$3.14M

10,066

0.0008%

$1.46M

—

WELTERS ANTHONY

Director

—

$2.68M (4) scheduled

−$2.68M

12,894

0.0010%

$1.87M

—

Whitley Richard James

Director

—

$2.55M (3) scheduled

−$2.55M

33,058

0.0027%

$4.80M

+31.5%

Kramer Kelly A.

Director

—

$713.19K (2) scheduled

−$713.19K

1,339

0.0001%

$194.54K

—

Rodriguez Javier

Director

—

$14.27K (1)

−$14.27K

13,364

0.0011%

$1.94M

+6,971%

BISCHOFBERGER NORBERT W

EVP, R&D and CSO

—

2,337,402

0.1885%

$339.60M

−0.1%

Lofton Kevin E

Director

—

101,095

0.0082%

$14.69M

+174.9%

Patterson Sandra

SVP, Controllership

—

39,453

0.0032%

$5.73M

+59.4%

McHutchison John G

Chief Scientific Off/HeadR&D

—

37,828

0.0031%

$5.50M

+65.1%

BARTON JACQUELINE K

Director

—

27,202

0.0022%

$3.95M

+105.1%

YOUNG KEVIN

Chief Operating Officer

—

25,612

0.0021%

$3.72M

+1,531%

Berger Dietmar

Chief Medical Officer

—

19,522

0.0016%

$2.84M

—

MANWANI HARISH

Director

—

15,015

0.0012%

$2.18M

—

MOORE NICHOLAS G

Director

—

12,233

0.0010%

$1.78M

−20.0%

Cain Wettan Keeley M

EVP Gen Counsel, Legal & Comp

—

8,759

0.0007%

$1.27M

+122.1%

Hamill Laura

EVP, Worldwide Commercial Ops

—

6,340

0.0005%

$921.14K

—

Horning Sandra

Director

—

6,293

0.0005%

$914.31K

—

LOVE TED W

Director

—

5,484

0.0004%

$796.77K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Lofton Kevin E

9 Mar 2023

Director

Exercised, kept

8,442

$52.38

$442.19K

Lofton Kevin E

28 Apr 2022

Director

Exercised, kept indirect

16,322

$25.63

$418.25K

Lofton Kevin E

22 Jan 2021

Director

Exercised, kept

20,282

$20.65

$418.72K

Lofton Kevin E

24 Feb 2020

Director

Exercised, kept

21,720

$19.63

$426.36K

Lofton Kevin E

24 Apr 2019

Director

Exercised, kept

13,208

$24.91

$328.95K

MILLIGAN JOHN F

27 Nov 2018

President and CEO

Exercised, kept

280,000

$23.60

$6.61M

MILLIGAN JOHN F

4 May 2018

President and CEO

Exercised, kept

80,000

$27.07

$2.17M

Showing 250 of 311 transactions. The figures above use every one of them.

By person

Individual transactions

What was left out